Study Investigating the Efficacy and Safety of the Addition of Oral-azacitidine to Salvage Treatment by Gilteritinib in Subjects ≥18 Years of Age With Relapsed/Refractory FLT3-mutated Acute Myeloid Leukemia

NOT_YET_RECRUITING

Amiens CHU, Amiens

RECRUITING

Angers CHU, Angers

NOT_YET_RECRUITING

Hôpital d'Instruction des Armées PERCY, Clamart

ACTIVE_NOT_RECRUITING

CHU Estaing, Clermont-Ferrand

NOT_YET_RECRUITING

Créteil CHU HENRI MONDOR, Créteil

RECRUITING

Grenoble CHU, Grenoble

NOT_YET_RECRUITING

CHU Lille, Lille

NOT_YET_RECRUITING

Limoges CHU, Limoges

NOT_YET_RECRUITING

Lyon sud CHU, Lyon

ACTIVE_NOT_RECRUITING

Marseille IPC, Marseille

ACTIVE_NOT_RECRUITING

Nantes CHU, Nantes

SUSPENDED

Centre Antoine Lacassagne, Nice

NOT_YET_RECRUITING

Paris Saint Louis, Paris

RECRUITING

Bordeaux CHU, Pessac

NOT_YET_RECRUITING

Rennes CHU, Rennes

NOT_YET_RECRUITING

Centre de Lutte Contre le Cancer H. Becquerel, Rouen

NOT_YET_RECRUITING

ICANS - Institut de cancérologie de strasbourg europe, Strasbourg

ACTIVE_NOT_RECRUITING

Toulouse - IUCT Oncopole - Service d'Hématologie, Toulouse

NOT_YET_RECRUITING

Nancy CHU, Vandœuvre-lès-Nancy

NOT_YET_RECRUITING

Versailles CH, Versailles